{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T18:55:28Z","timestamp":1789152928590,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002412","name":"Xi\u2019an Jiaotong University","doi-asserted-by":"publisher","award":["XJTU1AF2021LSL-029"],"award-info":[{"award-number":["XJTU1AF2021LSL-029"]}],"id":[{"id":"10.13039\/501100002412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002412","name":"Xi\u2019an Jiaotong University","doi-asserted-by":"publisher","award":["XJTU1AF2021LSL-029"],"award-info":[{"award-number":["XJTU1AF2021LSL-029"]}],"id":[{"id":"10.13039\/501100002412","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Innovation ability support plan of Shaan Xi province","award":["2022PT-24"],"award-info":[{"award-number":["2022PT-24"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-91888-y","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T01:51:17Z","timestamp":1741657877000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["TNMpBC-NeoBCSS model: a breast cancer specific survival prediction model for triple-negative metaplastic breast carcinoma patients with neoadjuvant therapy"],"prefix":"10.1038","volume":"15","author":[{"given":"Peng","family":"Ni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorong","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zejian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ligang","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bohui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanqun","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi long","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhishen","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yina","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,11]]},"reference":[{"issue":"13","key":"91888_CR1","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1200\/JCO.20.03399","volume":"39","author":"LA Korde","year":"2021","unstructured":"Korde, L. A. et al. Neoadjuvant chemotherapy, endocrine therapy, and targeted therapy for breast cancer: ASCO guideline. J. Clin. Oncol. 39 (13), 1485\u20131505. https:\/\/doi.org\/10.1200\/JCO.20.03399 (2021).","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"91888_CR2","doi-asserted-by":"publisher","first-page":"594","DOI":"10.6004\/jnccn.2023.0031","volume":"21","author":"WJ Gradishar","year":"2023","unstructured":"Gradishar, W. J. et al. NCCN Guidelines\u00ae insights: breast cancer, version 4.2023. J. Natl. Compr. Canc Netw. 21 (6), 594\u2013608. https:\/\/doi.org\/10.6004\/jnccn.2023.0031 (2023).","journal-title":"J. Natl. Compr. Canc Netw."},{"issue":"Suppl 10","key":"91888_CR3","doi-asserted-by":"publisher","first-page":"x231","DOI":"10.1093\/annonc\/mds324","volume":"23","author":"AM Thompson","year":"2012","unstructured":"Thompson, A. M. & Moulder-Thompson, S. L. Neoadjuvant treatment of breast cancer. Ann. Oncol. 23 (Suppl 10), x231\u2013x236. https:\/\/doi.org\/10.1093\/annonc\/mds324 (2012).","journal-title":"Ann. Oncol."},{"issue":"6","key":"91888_CR4","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.jamcollsurg.2015.02.011","volume":"220","author":"BK Killelea","year":"2015","unstructured":"Killelea, B. K. et al. Neoadjuvant chemotherapy for breast cancer increases the rate of breast conservation: results from the National Cancer database. J. Am. Coll. Surg. 220 (6), 1063\u20131069. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2015.02.011 (2015).","journal-title":"J. Am. Coll. Surg."},{"issue":"5","key":"91888_CR5","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1634\/theoncologist.2018-0228","volume":"24","author":"R Colomer","year":"2019","unstructured":"Colomer, R. et al. Neoadjuvant management of early breast cancer: A clinical and investigational position statement. Oncologist 24 (5), 603\u2013611. https:\/\/doi.org\/10.1634\/theoncologist.2018-0228 (2019).","journal-title":"Oncologist"},{"issue":"1","key":"91888_CR6","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.annonc.2019.10.012","volume":"31","author":"J Heil","year":"2020","unstructured":"Heil, J. et al. Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: Current evidence and future challenges. Ann. Oncol. 31 (1), 61\u201371. https:\/\/doi.org\/10.1016\/j.annonc.2019.10.012 (2020).","journal-title":"Ann. Oncol."},{"key":"91888_CR7","doi-asserted-by":"publisher","first-page":"101888","DOI":"10.1016\/j.ctrv.2019.08.004","volume":"79","author":"N Tray","year":"2019","unstructured":"Tray, N., Taff, J. & Adams, S. Therapeutic landscape of metaplastic breast cancer. Cancer Treat. Rev. 79, 101888. https:\/\/doi.org\/10.1016\/j.ctrv.2019.08.004 (2019).","journal-title":"Cancer Treat. Rev."},{"key":"91888_CR8","doi-asserted-by":"publisher","first-page":"583488","DOI":"10.3389\/fonc.2020.583488","volume":"10","author":"Y Ma","year":"2021","unstructured":"Ma, Y. et al. Research on the role of combined chemotherapy and radiotherapy in patients with N\u2009+\u2009Non-Metastatic metaplastic breast carcinoma: A competing risk analysis model based on the SEER database, 2000 to 2015. Front. Oncol. 10, 583488. https:\/\/doi.org\/10.3389\/fonc.2020.583488 (2021).","journal-title":"Front. Oncol."},{"issue":"1","key":"91888_CR9","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1038\/s41598-024-51627-1","volume":"14","author":"M Zhang","year":"2024","unstructured":"Zhang, M., Yuan, J., Wang, M., Zhang, M. & Chen, H. Chemotherapy is of prognostic significance to metaplastic breast cancer. Sci. Rep. 14 (1), 1210. https:\/\/doi.org\/10.1038\/s41598-024-51627-1 (2024).","journal-title":"Sci. Rep."},{"key":"91888_CR10","doi-asserted-by":"publisher","first-page":"103924","DOI":"10.1016\/j.critrevonc.2023.103924","volume":"182","author":"HR Thomas","year":"2023","unstructured":"Thomas, H. R. et al. Metaplastic breast cancer: A review. Crit. Rev. Oncol. Hematol. 182, 103924. https:\/\/doi.org\/10.1016\/j.critrevonc.2023.103924 (2023).","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"5","key":"91888_CR11","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.clbc.2017.04.009","volume":"7","author":"D El Zein","year":"2017","unstructured":"El Zein, D. et al. Metaplastic carcinoma of the breast is more aggressive than Triple-negative breast cancer: A study from a single institution and review of literature. Clin. Breast Cancer. 7 (5), 382\u2013391. https:\/\/doi.org\/10.1016\/j.clbc.2017.04.009 (2017).","journal-title":"Clin. Breast Cancer"},{"issue":"5","key":"91888_CR12","doi-asserted-by":"publisher","first-page":"3975","DOI":"10.3892\/ol.2016.5177","volume":"12","author":"T Bian","year":"2016","unstructured":"Bian, T. et al. Metaplastic carcinoma of the breast: Imaging and pathological features. Oncol. Lett. 12 (5), 3975\u20133980. https:\/\/doi.org\/10.3892\/ol.2016.5177 (2016).","journal-title":"Oncol. Lett."},{"issue":"3","key":"91888_CR13","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nrc3637","volume":"14","author":"B Weigelt","year":"2014","unstructured":"Weigelt, B., Eberle, C., Cowell, C. F., Ng, C. K. & Reis-Filho, J. S. Metaplastic breast carcinoma: More than a special type. Nat. Rev. Cancer. 14 (3), 147\u2013148. https:\/\/doi.org\/10.1038\/nrc3637 (2014).","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"91888_CR14","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s11912-014-0431-z","volume":"17","author":"S Abouharb","year":"2015","unstructured":"Abouharb, S. & Moulder, S. Metaplastic breast cancer: Clinical overview and molecular aberrations for potential targeted therapy. Curr. Oncol. Rep. 17 (3), 431. https:\/\/doi.org\/10.1007\/s11912-014-0431-z (2015).","journal-title":"Curr. Oncol. Rep."},{"issue":"12","key":"91888_CR15","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1007\/s00268-023-07106-1","volume":"47","author":"Y Tan","year":"2023","unstructured":"Tan, Y., Yang, B., Chen, Y. & Yan, X. Outcomes of metaplastic breast Cancer versus Triple-Negative breast cancer: A propensity score matching analysis. World J. Surg. 47 (12), 3192\u20133202. https:\/\/doi.org\/10.1007\/s00268-023-07106-1 (2023).","journal-title":"World J. Surg."},{"issue":"8","key":"91888_CR16","doi-asserted-by":"publisher","first-page":"4245","DOI":"10.1245\/s10434-020-09430-5","volume":"28","author":"AB Tadros","year":"2021","unstructured":"Tadros, A. B. et al. Survival outcomes for metaplastic breast Cancer differ by histologic subtype. Ann. Surg. Oncol. 28 (8), 4245\u20134253. https:\/\/doi.org\/10.1245\/s10434-020-09430-5 (2021).","journal-title":"Ann. Surg. Oncol."},{"issue":"4","key":"91888_CR17","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1093\/annonc\/mdl006","volume":"17","author":"BT Hennessy","year":"2006","unstructured":"Hennessy, B. T. et al. Biphasic metaplastic sarcomatoid carcinoma of the breast. Ann. Oncol. 17 (4), 605\u2013613. https:\/\/doi.org\/10.1093\/annonc\/mdl006 (2006).","journal-title":"Ann. Oncol."},{"issue":"3","key":"91888_CR18","doi-asserted-by":"publisher","first-page":"341","DOI":"10.5858\/arpa.2020-0830-OA","volume":"146","author":"E Abada","year":"2022","unstructured":"Abada, E. et al. Clinicopathologic characteristics and outcome descriptors of metaplastic breast carcinoma. Arch. Pathol. Lab. Med. 146 (3), 341\u2013350. https:\/\/doi.org\/10.5858\/arpa.2020-0830-OA (2022).","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"1","key":"91888_CR19","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41523-021-00302-z","volume":"7","author":"W Wong","year":"2021","unstructured":"Wong, W. et al. Poor response to neoadjuvant chemotherapy in metaplastic breast carcinoma. NPJ Breast Cancer. 7 (1), 96. https:\/\/doi.org\/10.1038\/s41523-021-00302-z (2021).","journal-title":"NPJ Breast Cancer"},{"issue":"3","key":"91888_CR20","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s10549-019-05264-2","volume":"176","author":"Z Al-Hilli","year":"2019","unstructured":"Al-Hilli, Z. et al. Metaplastic breast cancer has a poor response to neoadjuvant systemic therapy. Breast Cancer Res. Treat. 176 (3), 709\u2013716. https:\/\/doi.org\/10.1007\/s10549-019-05264-2 (2019).","journal-title":"Breast Cancer Res. Treat."},{"issue":"5","key":"91888_CR21","doi-asserted-by":"publisher","first-page":"e691","DOI":"10.1016\/j.clbc.2022.01.006","volume":"22","author":"W Haque","year":"2022","unstructured":"Haque, W. et al. Neoadjuvant chemotherapy for metaplastic breast cancer: response rates, management, and outcomes. Clin. Breast Cancer. 22 (5), e691\u2013e699. https:\/\/doi.org\/10.1016\/j.clbc.2022.01.006 (2022).","journal-title":"Clin. Breast Cancer"},{"issue":"13","key":"91888_CR22","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1158\/1078-0432.CCR-21-3100","volume":"28","author":"C Yam","year":"2022","unstructured":"Yam, C. et al. Molecular characterization and prospective evaluation of pathologic response and outcomes with neoadjuvant therapy in metaplastic Triple-Negative breast Cancer. Clin. Cancer Res. 28 (13), 2878\u20132889. https:\/\/doi.org\/10.1158\/1078-0432.CCR-21-3100 (2022).","journal-title":"Clin. Cancer Res."},{"key":"91888_CR23","doi-asserted-by":"publisher","first-page":"1030124","DOI":"10.3389\/fonc.2023.1030124","volume":"13","author":"C Zheng","year":"2023","unstructured":"Zheng, C. et al. Clinical characteristics and overall survival prognostic nomogram for metaplastic breast cancer. Front. Oncol. 13, 1030124. https:\/\/doi.org\/10.3389\/fonc.2023.1030124 (2023).","journal-title":"Front. Oncol."},{"issue":"1","key":"91888_CR24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.17305\/bjbms.2021.5911","volume":"22","author":"Y Li","year":"2022","unstructured":"Li, Y. et al. Construction and validation of prognostic nomogram for metaplastic breast cancer. Bosn J. Basic. Med. Sci. 22 (1), 131\u2013139. https:\/\/doi.org\/10.17305\/bjbms.2021.5911 (2022).","journal-title":"Bosn J. Basic. Med. Sci."},{"issue":"4","key":"91888_CR25","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1245\/s10434-017-6316-2","volume":"25","author":"W Haque","year":"2018","unstructured":"Haque, W., Verma, V., Naik, N., Butler, E. B. & Teh, B. S. Metaplastic breast cancer: Practice patterns, outcomes, and the role of radiotherapy. Ann. Surg. Oncol. 25 (4), 928\u2013936. https:\/\/doi.org\/10.1245\/s10434-017-6316-2 (2018).","journal-title":"Ann. Surg. Oncol."},{"issue":"1","key":"91888_CR26","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1186\/s12905-023-02513-x","volume":"23","author":"J Tang","year":"2023","unstructured":"Tang, J., Zhang, D. & Pan, X. Development and validation of competitive risk model for older women with metaplastic breast cancer. BMC Womens Health. 23 (1), 374. https:\/\/doi.org\/10.1186\/s12905-023-02513-x (2023).","journal-title":"BMC Womens Health"},{"key":"91888_CR27","doi-asserted-by":"publisher","unstructured":"Th\u00e9riault, K. et al. A Single-Center 18-Year Series of 73 Cases of Metaplastic Carcinoma of the Breast. Breast J. ; 2024:5920505. (2024). https:\/\/doi.org\/10.1155\/2024\/5920505","DOI":"10.1155\/2024\/5920505"},{"issue":"5","key":"91888_CR28","first-page":"400","volume":"49","author":"WT Yang","year":"2020","unstructured":"Yang, W. T. & BuH Updates in the 5(th) edition of WHO classification of tumours of the breast. Zhonghua Bing Li Xue Za Zhi. 49 (5), 400\u2013405 (2020).","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"issue":"2","key":"91888_CR29","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/bjc.2014.592","volume":"112","author":"EA Rakha","year":"2015","unstructured":"Rakha, E. A. et al. Prognostic factors in metaplastic carcinoma of the breast: a multi-institutional study. Br. J. Cancer. 112 (2), 283\u2013289. https:\/\/doi.org\/10.1038\/bjc.2014.592 (2015).","journal-title":"Br. J. Cancer"},{"key":"91888_CR30","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.breast.2021.11.015","volume":"60","author":"Z Yang","year":"2021","unstructured":"Yang, Z. et al. Research on the cutoff tumor size of omitting radiotherapy for BCSS after breast conserving surgery in women aged 65 years or Oder with low-risk invasive breast carcinoma: results based on the SEER database. Breast 60, 287\u2013294. https:\/\/doi.org\/10.1016\/j.breast.2021.11.015 (2021).","journal-title":"Breast"},{"issue":"10","key":"91888_CR31","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1002\/cac2.12195","volume":"41","author":"D Jiang","year":"2021","unstructured":"Jiang, D. et al. Trends in cancer mortality in China from 2004 to 2018: A nationwide longitudinal study. Cancer Commun. (Lond). 41 (10), 1024\u20131036 (2021).","journal-title":"Cancer Commun. (Lond)"},{"issue":"8","key":"91888_CR32","doi-asserted-by":"publisher","first-page":"e2120951","DOI":"10.1001\/jamanetworkopen.2021.20951","volume":"4","author":"C Seldon","year":"2021","unstructured":"Seldon, C. et al. Variation in management of extremity Soft-Tissue sarcoma in younger vs older adults. JAMA Netw. Open. 4 (8), e2120951 (2021).","journal-title":"JAMA Netw. Open."},{"issue":"3","key":"91888_CR33","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s10549-010-0780-8","volume":"120","author":"SY Jung","year":"2010","unstructured":"Jung, S. Y. et al. Worse prognosis of metaplastic breast cancer patients than other patients with triple-negative breast cancer. Breast Cancer Res. Treat. 120 (3), 627\u2013637. https:\/\/doi.org\/10.1007\/s10549-010-0780-8 (2010).","journal-title":"Breast Cancer Res. Treat."},{"issue":"3","key":"91888_CR34","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/tbj.13234","volume":"25","author":"S Takala","year":"2019","unstructured":"Takala, S., Heikkil\u00e4, P., Nevanlinna, H., Blomqvist, C. & Mattson, J. Metaplastic carcinoma of the breast: prognosis and response to systemic treatment in metastatic disease. Breast J. 25 (3), 418\u2013424. https:\/\/doi.org\/10.1111\/tbj.13234 (2019).","journal-title":"Breast J."},{"key":"91888_CR35","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S0140-6736(13)62422-8","volume":"384","author":"P Cortazar","year":"2014","unstructured":"Cortazar, P. et al. Pathological complete response and long-term clinical benefit in breast cancer: The CTNeoBC pooled analysis. Lancet 384, 164\u2013172 (2014).","journal-title":"Lancet"},{"issue":"4","key":"91888_CR36","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1002\/ijc.33830","volume":"150","author":"L Zhang","year":"2022","unstructured":"Zhang, L. et al. Neoadjuvant docetaxel plus carboplatin vs epirubicin plus cyclophosphamide followed by docetaxel in triple-negative, early-stage breast cancer (NeoCART): Results from a multicenter, randomized controlled, open-label phase II trial. Int. J. Cancer. 150 (4), 654\u2013662.  (2022).","journal-title":"Int. J. Cancer"},{"key":"91888_CR37","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01506","author":"JH Shepherd","year":"2022","unstructured":"Shepherd, J. H. et al. CALGB 40603 (Alliance): Long-Term outcomes and genomic correlates of response and survival after neoadjuvant chemotherapy with or without carboplatin and bevacizumab in Triple-Negative breast Cancer. J. Clin. Oncol. https:\/\/doi.org\/10.1200\/JCO.21.01506 (2022).","journal-title":"J. Clin. Oncol."},{"key":"91888_CR38","doi-asserted-by":"publisher","first-page":"924342","DOI":"10.3389\/fonc.2022.924342","volume":"12","author":"K Zhu","year":"2022","unstructured":"Zhu, K. et al. Prognostic factor analysis and model construction of Triple-Negative metaplastic breast carcinoma after surgery. Front. Oncol. 12, 924342.  (2022).","journal-title":"Front. Oncol."},{"issue":"1","key":"91888_CR39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s10549-023-06945-9","volume":"200","author":"J Hu","year":"2023","unstructured":"Hu, J. et al. The mixed subtype has a worse prognosis than other histological subtypes: A retrospective analysis of 217 patients with metaplastic breast cancer. Breast Cancer Res. Treat. 200 (1), 23\u201336. https:\/\/doi.org\/10.1007\/s10549-023-06945-9 (2023).","journal-title":"Breast Cancer Res. Treat."},{"issue":"12","key":"91888_CR40","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.5858\/arpa.2019-0396-RA","volume":"143","author":"ER McMullen","year":"2019","unstructured":"McMullen, E. R., Zoumberos, N. A. & Kleer, C. G. Metaplastic breast carcinoma: Update on histopathology and molecular alterations. Arch. Pathol. Lab. Med. 143 (12), 1492\u20131496. https:\/\/doi.org\/10.5858\/arpa.2019-0396-RA (2019).","journal-title":"Arch. Pathol. Lab. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91888-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91888-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91888-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T13:34:11Z","timestamp":1741700051000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91888-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,11]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["91888"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-91888-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4918831\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,11]]},"assertion":[{"value":"15 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All procedures in this study was performed in accordance with approved guidelines. This study was approved by the Ethics Committee of the First Affiliated Hospital of Xi\u2019an Jiao tong University. The ethic number, No: XJTU1AF2024LSYY-168.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"8351"}}